Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Compounds from Etlingera alba may help treat Triple Negative Breast Cancer.

PF-998425 is a new, effective, and non-phototoxic treatment for skin conditions related to androgens.

A rare benign ovarian tumor caused virilization in a postmenopausal woman, treated successfully with surgery.

Oral contraceptives help treat hyperandrogenic disorders, improving symptoms like excessive hair and acne.

Exercising women with irregular periods have lower thyroid hormone levels and less body fat.

The combination of Stemoxydine® and Resveratrol improves hair density in women with Female Pattern Hair Loss.

Testosterone increases 3α-androstanediol levels, which can be blocked by finasteride.

Spironolactone effectively treats hormonal acne, hair loss, and excess hair growth in women.

Testosterone and dihydrotestosterone play a role in women's health issues like excess hair and baldness, and treatments blocking these hormones may help.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

A woman's severe insulin resistance improved with treatment, but she still had high testosterone levels due to ovarian issues.

A new method was developed to purify finasteride for better medical use.

Cyproterone acetate is a safe treatment that causes mild feminizing effects and is more effective with added estrogens.

Testosterone affects androgen receptors and lipid storage in cells, while DHEA does not convert to testosterone or affect these receptors in the same way.

A postmenopausal woman had high testosterone from her right adrenal gland, leading to recommended surgery.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Most patients tolerated spironolactone for acne and hirsutism despite common side effects like menstrual changes and breast tenderness.

Cyproterone acetate is effective for treating hirsutism and acne in women by blocking androgens in the skin and also works as a contraceptive.

Testosterone therapy can modestly improve sexual function in menopausal women but should be used cautiously and is not recommended for routine measurement in sexual dysfunction or hirsutism.

Hirsutism treatments can slow new hair growth, but existing hair needs removal, and eflornithine helps reduce hair growth.

Hormone therapies like birth control pills and spironolactone are safe and effective for treating women's adult acne.

The "Flavosterol" emulgel meets quality standards for treating hair loss.

Women have a higher risk of blood clots from hormonal factors and need careful treatment, especially during pregnancy.

The method can measure multiple hormones in women's hair and may help identify hormone-related health issues.

The paper suggests that France's suspension of Diane-35 was hasty and could cause treatment issues and unintended pregnancies, recommending a re-evaluation and better patient information.

Stigmasterol may help treat hair loss, but more research is needed.

Low-dose flutamide helps reduce excessive hair growth and is even more effective with birth control, without bad effects on blood fats.

Dienogest is safer and has fewer side effects than GnRH analogues for treating endometriosis.

Menopause and aging can affect women's quality of life and sexuality, but hormone therapies may help alleviate these issues.